Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1508 ARTÍCULOS , VIENDO DEL 286 AL 300

Physical Exercise and Brain Mitochondrial Fitness: The Possible Role Against Alzheimer's Disease

Bernardo TC, Marques-Aleixo I, Beleza J, Oliveira PJ, Ascensão A, Magalhães J.

Brain Pathol. 2016 Sep;26(5):648-63. doi: 10.1111/bpa.12403.

The TOMM40 gene rs2075650 polymorphism contributes to Alzheimer's disease in Caucasian, and Asian populations

Huang H, Zhao J, Xu B, Ma X, Dai Q, Li T, Xue F, Chen B.

Neurosci Lett. 2016 Aug 15;628:142-6. doi: 10.1016/j.neulet.2016.05.050. Epub 2016 Jun 18.

Apolipoprotein E as a Therapeutic Target in Alzheimer's Disease: A Review of Basic Research and Clinical Evidence

Yamazaki Y, Painter MM, Bu G, Kanekiyo T.

CNS Drugs. 2016 Sep;30(9):773-89. doi: 10.1007/s40263-016-0361-4.

Insights on the pathophysiology of Alzheimer's disease: The crosstalk between amyloid pathology, neuroinflammation and the peripheral immune system

Dá Mesquita S, Ferreira AC, Sousa JC, Correia-Neves M, Sousa N, Marques F.

Neurosci Biobehav Rev. 2016 Sep;68:547-562. doi: 10.1016/j.neubiorev.2016.06.014. Epub 2016 Jun 18.

Cystatin C in aging and in Alzheimer's disease

Mathews PM, Levy E.

Ageing Res Rev. 2016 Dec;32:38-50. doi: 10.1016/j.arr.2016.06.003. Epub 2016 Jun 19.

Long-term safety and tolerability of bapineuzumab in patients with Alzheimer's disease in two phase 3 extension studies

Ivanoiu A, Pariente J, Booth K, Lobello K, Luscan G, Hua L, Lucas P, Styren S, Yang L, Li D, Black RS, Brashear HR, McRae T.

Alzheimers Res Ther. 2016 Jun 23;8(1):24. doi: 10.1186/s13195-016-0193-y.

Multi-Nutrient Dietary Intervention Approach to the Management of Alzheimer's Disease - A Mini-Review

Klimova B, Kuca K.

Curr Alzheimer Res. 2016;13(12):1312-1318. doi: 10.2174/1567205013666160603000623.

Folic Acid Supplementation Mitigates Alzheimer's Disease by Reducing Inflammation: A Randomized Controlled Trial

Chen H, Liu S, Ji L, Wu T, Ji Y, Zhou Y, Zheng M, Zhang M, Xu W, Huang G.

Mediators Inflamm. 2016;2016:5912146. doi: 10.1155/2016/5912146. Epub 2016 Jun 2.

Intracellular Calcium Dysregulation: Implications for Alzheimer's Disease

Magi S, Castaldo P, Macrì ML, Maiolino M, Matteucci A, Bastioli G, Gratteri S, Amoroso S, Lariccia V.

Biomed Res Int. 2016;2016:6701324. doi: 10.1155/2016/6701324. Epub 2016 Jun 2.

Effect of aerobic exercise on physical performance in patients with Alzheimer's disease

Sobol NA, Hoffmann K, Frederiksen KS, Vogel A, Vestergaard K, Brændgaard H, Gottrup H, Lolk A, Wermuth L, Jakobsen S, Laugesen L, Gergelyffy R, Høgh P, Bjerregaard E, Siersma V, Andersen BB, Johannsen P, Waldemar G, Hasselbalch SG, Beyer N.

Alzheimers Dement. 2016 Dec;12(12):1207-1215. doi: 10.1016/j.jalz.2016.05.004. Epub 2016 Jun 23.

Combination Therapy Showed Limited Superiority Over Monotherapy for Alzheimer Disease: A Meta-analysis of 14 Randomized Trials

Tsoi KK, Chan JY, Leung NW, Hirai HW, Wong SY, Kwok TC.

J Am Med Dir Assoc. 2016 Sep 1;17(9):863.e1-8. doi: 10.1016/j.jamda.2016.05.015. Epub 2016 Jun 24.

Aβ-Degrading Proteases: Therapeutic Potential in Alzheimer Disease

Leissring MA.

CNS Drugs. 2016 Aug;30(8):667-75. doi: 10.1007/s40263-016-0364-1.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias